Profile
Doo-Seop Kim worked as a Medicinal Chemist at Merck & Co., Inc. and later as the Head of New Medicine Research Institute at Handok, Inc. He then became the Vice President and Head of Research at Kainos Medicine, Inc. where he worked until 2012.
Dr. Kim holds a doctorate degree from the University of Pittsburgh, a graduate degree from Seoul National University, and an undergraduate degree from Sungkyunkwan University.
Former positions of Doo-Seop Kim
| Companies | Position | End |
|---|---|---|
| HANDOK INC. | Corporate Officer/Principal | 01/01/2015 |
Kainos Medicine, Inc. /old/
 Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Corporate Officer/Principal | 01/11/2012 |
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Chief Tech/Sci/R&D Officer | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Doo-Seop Kim
| Sungkyunkwan University | Undergraduate Degree |
| Seoul National University | Graduate Degree |
| University of Pittsburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| HANDOK INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Stock Market
- Insiders
- Doo-Seop Kim
